Experience/Therapeutic areas
Novum’s Clinical Pharmacology Research Unit in Las Vegas, NV, has decades of experience in handling various dosage forms and study types conducted in healthy volunteers. The Clinical Trial Management Group at Novum manages all Early Clinical Development studies that need to be conducted in patients.
Leverage Extensive Capabilities for Early-Phase Studies
- Single / Multiple Ascending Dose (SAD/MAD)
- First-in-human (FIH)
- BA/BE Biocomparison
- Biosimilars
- Drug-Drug Interaction
- Food-Drug Interaction
- Drug-Device Combinations
- PK-PD Proof-of-Concept
- Irritation Sensitization Adhesion
- Food effect studies
- Cardiac Safety studies
- Inhalation studies
- Dermatology Studies
- Human Factor Studies
- Self-administration Studies
- Potency Ranking Studies
- Special Patient Populations
Comprehensive Expertise in Various Dosage Forms and Therapeutic Products
- Oral Dosage Forms
- Respiratory Products (Nasal Sprays & Inhalation – MDI, DPI)
- Topical Products and Transdermal Systems
- Injectables IV/IM/SC
- Biologics
- Locally Acting Products
- Natural Source Products
- Vaginal Products
- Rectal Products
Experience in Patient-Based Studies Across Diverse Therapeutic Areas
- Oncology & Hematology
- Neurology
- Respiratory
- Dermatology
- Women’s Health
- Autoimmune Diseases
Clinical Pharmacological Unit (Las Vegas, USA)
- 37,000 sq ft state-of-the-art facility
- 4 specialized clinics with a total of 191 beds for early-phase trials
- 15-bed dedicated unit for Phase-I (FIH) studies
- Exclusive Outpatient/Returns clinic for enhanced patient care
- Effective recruitment and retention of normal, healthy and specialty patient populations.
